Green Thumb Industries (GTBIF) Net Cash Flow (2019 - 2026)
Green Thumb Industries (GTBIF) posted Net Cash Flow of $60.9 million for Q1 2026, up 22.18% on a QoQ basis from $49.9 million in Q4 2025, and up 56.65% year-over-year from $38.9 million in Q1 2025.
Green Thumb Industries (GTBIF) Net Cash Flow (2019 - 2026) Analysis & Trends
Green Thumb Industries' Net Cash Flow history runs 8 years deep, the most recent figure standing at $60.9 million for Q1 2026.
- Quarterly Net Cash Flow rose 56.65% year-over-year to $60.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $135.6 million (up 1115.57% YoY) and the FY2025 annual result came in at $113.6 million, up 1029.96% from the prior year.
- Net Cash Flow was $60.9 million for Q1 2026 at Green Thumb Industries, up from $49.9 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $62.3 million in Q1 2024 and bottomed at -$55.9 million in Q1 2022.
- A 5-year average of $6.8 million and a median of $2.0 million in 2022 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2023 — Net Cash Flow slumped 715.04% — and 2025, when it soared 2652.15%.
- Green Thumb Industries' Net Cash Flow stood at $30.4 million in 2022, then retreated by 18.51% to $24.8 million in 2023, then slumped by 107.88% to -$2.0 million in 2024, then surged by 2652.15% to $49.9 million in 2025, then rose by 22.18% to $60.9 million in 2026.
- Business Quant data shows GTBIF's Net Cash Flow at $60.9 million in Q1 2026, $49.9 million in Q4 2025, and $58.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 202.00 Mn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -526.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 711.50 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -277.40 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 461.90 Mn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -112.00 Mn |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn | 60.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60.93 Mn |
| Mar 31, 2026 | 60.93 Mn |
| Dec 31, 2025 | 49.87 Mn |
| Dec 31, 2025 | 49.87 Mn |
| Sep 30, 2025 | 58.49 Mn |
| Sep 30, 2025 | 58.49 Mn |
| Jun 30, 2025 | -33.66 Mn |
| Jun 30, 2025 | -33.66 Mn |
| Mar 31, 2025 | 38.90 Mn |
| Mar 31, 2025 | 38.90 Mn |
| Dec 31, 2024 | -1.95 Mn |
| Dec 31, 2024 | -1.95 Mn |
| Sep 30, 2024 | -22.50 Mn |
| Sep 30, 2024 | -22.50 Mn |
| Jun 30, 2024 | -27.80 Mn |
| Jun 30, 2024 | -27.80 Mn |
| Mar 31, 2024 | 62.30 Mn |
| Mar 31, 2024 | 62.30 Mn |
| Dec 31, 2023 | 24.79 Mn |
| Dec 31, 2023 | 24.79 Mn |